Aster Investment Management’s Edwards Lifesciences EW Stock Holding History

Aster Investment Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$34M	Buy	+3,040,200	New	+$36M	1.27%	32

Other funds holding EW

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Aster Investment Management's EW Position: Q2 2013 in Review

Aster Investment Management opened a new position in Edwards Lifesciences (EW) in Q2 2013: 3,040,200 shares worth $34M. The stake represents 1.27% of the portfolio and ranks #32 among its holdings.

375 funds tracked by Wall St. Rank hold EW as of Q2 2013.

Aster Investment Management held 3,040,200 shares of Edwards Lifesciences worth $34M as of Q2 2013.
Edwards Lifesciences was a new Aster Investment Management position in Q2 2013.
Edwards Lifesciences made up 1.27% of Aster Investment Management's portfolio in Q2 2013, its #32 holding.
375 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2013.

Based on Aster Investment Management's 13F filing for Q2 2013, filed 29 Jul 2013.